Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-21), CVS Health's 12-1 Month Momentum % is N/A%.
The industry rank for CVS Health's 12-1 Month Momentum % or its related term are showing as below:
XSWX:CVS's 12-1 Month Momentum % is not ranked *
in the Healthcare Plans industry.
Industry Median: 27.81 * Ranked among companies with meaningful 12-1 Month Momentum % only.
CVS Health (XSWX:CVS) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
CVS Health (XSWX:CVS) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Health (XSWX:CVS) has a 12-1 Month Momentum % of N/A% as of Aug. 21, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on CVS Health and its competitors. According to the industry distribution chart, CVS Health ranks #4 out of 18 companies in the Healthcare Plans industry, placing it in the top 22.2%.
Is CVS Health's 12-1 Month Momentum % too high?
CVS Health's current 12-1 Month Momentum % is N/A%. Based on the distribution chart, CVS Health ranks #4 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, CVS Health has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does CVS Health's 12-1 Month Momentum % compare to ELV and CI?
According to the Healthcare Plans industry distribution chart, CVS Health ranks #4 out of 18 companies for 12-1 Month Momentum %. This places CVS Health in the top 22% of its industry — outperforming the majority of peers. The industry median 12-1 Month Momentum % is 27.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Plans company?
The median 12-1 Month Momentum % among Healthcare Plans companies is 27.81, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on CVS Health and its competitors. For the Healthcare Plans industry, the median 12-1 Month Momentum % is 27.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Health's current 12-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
CVS Health (XSWX:CVS) has a current 12-1 Month Momentum % of N/A%. The stock's GF Value™ is CHF63.11, compared to a current price of CHF75.02 — trading 18.9% above its estimated fair value. The current 12-1 Month Momentum % is N/A%. CVS Health's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For CVS Health (XSWX:CVS), the current 12-1 Month Momentum % is N/A% as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Health (XSWX:CVS) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Health stock appears to be overvalued.
The current stock price of CHF75.02 is trading 18.9% above its estimated GF Value™ of CHF63.11.
Key valuation signals for XSWX:CVS:
12-1 Month Momentum %: N/A%
GF Value™: CHF63.11 vs. price of CHF75.02 (18.9% above fair value)
No single metric tells the full story. See the XSWX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
76GF Score
Get the complete analysis for XSWX:CVS
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CVS has been successfully added to your 
